148
Views
4
CrossRef citations to date
0
Altmetric
CASE SERIES

Clinical Characteristics of Transplant Recipients Infected with Talaromyces Marneffei: 2 Case Reports and a Literature Review

, , , , &
Pages 2879-2890 | Published online: 03 Jun 2022

References

  • Deng Z, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis. 1988;10(3):640–652. doi:10.1093/clinids/10.3.640
  • Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50:1101–1111.
  • Hung CC, Hsueh PR, Chen MY, Hsiao CH, Chang SC, Luh KT. Invasive infection caused by Penicillium marneffei: an emerging pathogen in Taiwan. Clin Infect Dis. 1998;26:202–203.
  • Ko CI, Hung CC, Chen MY, Hsueh PR, Hsiao CH, Wong JM. Endoscopic diagnosis of intestinal Penicilliosis marneffei: report of three cases and review of the literature. Gastrointest Endosc. 1999;50:111–114.
  • Wang JL, Hung CC, Chang SC, Chueh SC, La MK. Disseminated Penicillium marneffei infection in a renal-transplant recipient successfully treated with liposomal amphotericin B. Transplantation. 2003;76:1136–1137.
  • Chan YH, Wong KM, Lee KC, et al. Pneumonia and mesenteric lymphadenopathy caused by disseminated Penicillium marneffei infection in a cadaveric renal transplant recipient. Transpl Infect Dis. 2004;6:28–32.
  • Lin JN, Lin HH, Lai CH, Wang JL, Yu TJ. Renal transplant recipient infected with Penicillium marneffei. Lancet Infect Dis. 2010;10:138.
  • Hart J, Dyer JR, Clark BM, McLellan DG, Perera S, Ferrari P. Travel-related disseminated Penicillium marneffei infection in a renal transplant patient. Transpl Infect Dis. 2012;14:434–439.
  • Zeng X, Tan D, Jiang Y. A case of Talaromyces marneffei infection after kidney transplantation. Chin J Lung Dis. 2017;10:751–753.
  • Zhou X. A case of Penicilliosis marneffei infection after kidney transplantation. Natl Med J China. 2002;11:44.
  • Chen T, Kong Y, Luo Y, Lin M, Xu J. A case of renal transplantation complicated with Penicillium marneffei infection. Chin J Tissue Eng Res. 2011;15:10068–10070.
  • Peng J, Chen Z, Cai R, et al. Recovery from Talaromyces marneffei involving the kidney in a renal transplant recipient: a case report and literature review. Transpl Infect Dis. 2017;19:548. doi:10.1111/tid.12710
  • Sethuraman N, Thirunarayan MA, Gopalakrishnan R, Rudramurthy S, Ramasubramanian V, Parameswaran A. Talaromyces marneffei outside endemic areas in India: an emerging infection with atypical clinical presentations and review of published reports from India. Mycopathologia. 2020;185:893–904.
  • Woo PCY, Lau SKP, Lau CCY, et al. Penicillium marneffei fungaemia in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant. 2005;35:831–833.
  • Stathakis A, Lim KP, Boan P, et al. Penicillium marneffei infection in a lung transplant recipient. Transpl Infect Dis. 2015;17:429–434.
  • Hermans F, Ombelet S, Degezelle K, et al. First-in-man observation of Talaromyces marneffei-transmission by organ transplantation. Mycoses. 2017;60:213–217.
  • Seo JY, Ma YE, Lee JH, Lee ST, Ki CS, Lee NY. A case of disseminated Penicillium marneffei infection in a liver transplant recipient. Korean J Lab Med. 2010;30:400–405.
  • Xu Q, Zhang X. Nursing of a case with Talaromyces marneffei infection after liver transplantation. World Latest Med Inf. 2020;1:27. doi:10.3969/j.issn.1671-3141.2020.27.133
  • Xu C, Zhou C, Chen Y, Sun Y, Wu Q. Simultaneous urine and pulmonary alveolar lavage fluid detection in HIV-negative patients with Penicillium marneffei. Zhejiang Med J. 2018;40:2595–6+622.
  • Vergidis P, Rao A, Moore CB, et al. Talaromycosis in a renal transplant recipient returning from South China. Transpl Infect Dis. 2021;23:e13447.
  • Bai M, Gu Y, Zhou J, et al. A case of disseminated Penicillium marneffei infection. J Diagn Concepts Pract. 2008;17:715–717.
  • Guo L, Lin Y. Clinical pharmacists participate in the treatment of Penicillium marneffei patients to find the clinical entry point. China J Pharm Econ. 2014;9:116–117.
  • Wang W, Kang Y, Gao S, Yu L, Liu Y, Shen Z. A case report of fatal Penicilliosis marneffei after liver transplantation. Pract J Organ Transplant. 2018;6:222–225.
  • Zhu YM, Ai JW, Xu B, et al. Rapid and precise diagnosis of disseminated T. marneffei infection assisted by high-throughput sequencing of multifarious specimens in a HIV-negative patient: a case report. BMC Infect Dis. 2018;18:379.
  • Gu W, Miller S, Chiu CY. Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection. Annu Rev Pathol. 2019;14:319–338. doi:10.1146/annurev-pathmechdis-012418-012751
  • Chiu CY. Viral pathogen discovery. Curr Opin Microbiol. 2013;16(4):468–478. doi:10.1016/j.mib.2013.05.001
  • Salipante SJ, Hoogestraat DR, Abbott AN, et al. Coinfection of Fusobacterium nucleatum and Actinomyces israelii in mastoiditis diagnosed by next-generation DNA sequencing. J Clin Microbiol. 2014;52(5):1789–1792. doi:10.1128/JCM.03133-13
  • Charlson ES, Diamond JM, Bittinger K, et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med. 2012;186:536–545.
  • Li X, Zheng Y, Wu F, et al. Evaluation of quantitative real-time PCR and Platelia galactomannan assays for the diagnosis of disseminated Talaromyces marneffei infection. Med Mycol. 2020;58(2):181–186. doi:10.1093/mmy/myz052
  • Raju S, Ghosh S, Mehta AC. Chest CT signs in pulmonary disease: a pictorial review. Chest. 2017;151:1356–1374.
  • José RJ, Periselneris JN, Brown JS. Opportunistic bacterial, viral and fungal infections of the lung. Medicine. 2020;48:366–372.
  • Franquet T, Müller NL, Giménez A, Guembe P, de La Torre J, Bagué S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics. 2001;21(4):825–837. doi:10.1148/radiographics.21.4.g01jl03825
  • Zhou F, Bi X, Zou X, Xu Z, Zhang T. Retrospective analysis of 15 cases of Penicilliosis marneffei in a southern China hospital. Mycopathologia. 2014;177(5–6):271–279. doi:10.1007/s11046-014-9737-5
  • Shen Z, Li S, Yang J, et al. 23 cases clinical study of pneumocystis pneumonia after hematopoietic stem cell transplantation. Chin J Emerg Med. 2021;30:1248–1253.
  • Le T, Kinh N, Ngo C, et al. A trial of itraconazole or amphotericin B for HIV-associated talaromycosis. N Engl J Med. 2017;376:2329–2340.
  • Huang W, Li T, Zhou C, Wei F, Cao C, Jiang J. Voriconazole versus amphotericin B as induction therapy for talaromycosis in HIV/AIDS patients: a retrospective study. Mycopathologia. 2021;186:269–276.
  • Niwa T, Shiraga T, Takagi A. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull. 2005;28:1805–1808.
  • Sattler M, Guengerich FP, Yun CH, Christians U, Sewing KF. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos. 1992;20:753–761.
  • Vanhove T, Bouwsma H, Hilbrands L, et al. Determinants of the magnitude of interaction between Tacrolimus and Voriconazole/Posaconazole in solid organ recipients. Am J Transplant. 2017;17:2372–2380.
  • Zhang X, Hu J, Hu Y, et al. Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: a Retrospective Analysis of Patients with Hematological Malignancies in China. Med Sci Monit. 2018;24:5258–5270. doi:10.12659/MSM.908831
  • Zhang J, Liu H, Xi L, Chang YC, Kwon-Chung KJ, Seyedmousavi S. Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of Talaromyces marneffei. Antimicrob Agents Chemother. 2021;65(6):e00256–21. doi:10.1128/AAC.00256-21